In Vivo Pharmacokinetics of Bromfenac Ophthalmic Solution 0.075%, Bromfenac Ophthalmic Solution 0.07%, and Nepafenac/Amfenac Ophthalmic Suspension 0.3% in Rabbits

INTRODUCTION: Little is known of the ocular distribution characteristics of currently branded non-steroidal anti-inflammatory drugs (NSAIDs) in the United States. This study was designed to predict the ocular bioavailability characteristics in humans using Dutch Belted rabbits as a surrogate. Commer...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheppard, John D., Cockrum, Paul C., Justice, Angela, Jasek, Mark C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997598/
https://www.ncbi.nlm.nih.gov/pubmed/29761367
http://dx.doi.org/10.1007/s40123-018-0130-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997598/
https://www.ncbi.nlm.nih.gov/pubmed/29761367
http://dx.doi.org/10.1007/s40123-018-0130-1

Ejemplares similares